WPRIM Management System> DCMS> Chinese Journal of Nuclear Medicine and Molecular Imaging> 2022> 42> 11

Volume: 42 Issue: 11

1. Serologically biochemical evaluation for patients with locally advanced/metastatic radioactive iodine-refractory differentiated thyroid cancer treated by apatinib Page:644—649
2. Preliminary study of apatinib combined with 131I therapy in patients with progressive metastatic differentiated thyroid cancer Page:650—655
3. Short-term effect of targeted drugs on quality of life in patients with radioactive iodine-refractory differentiated thyroid cancer Page:656—660
4. Study of altered brain metabolism and connectivity in temporal lobe epilepsy Page:661—665
5. Efficacy and prognostic factors analysis of CT-guided 125I seeds implantation for primary hepatocellular carcinoma Page:666—671
6. Automatic synthesis and myocardial imaging of 11C-meta-hydroxyephedrine Page:672—675
7. Preparation and microPET imaging of extradomain-B fibronectin specific probe 18F-AlF-NOTA-PEG 4-ZD2 Page:676—680
8. Research progress in thyroid cancer: dedifferentiation mechanisms and differentiation therapies Page:686—691
9. Research progress of peptide receptor radionuclide therapy combined with other drugs in the treatment of neuroendocrine tumors Page:692—695

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.